Lorena Hoyos

A short protocol using dexamethasone and monophosphoryl lipid A generates tolerogenic dendritic cells that display a potent migratory capacity to lymphoid chemokines

M. Molina, J. Aguillón, B. Pesce, 2013, Journal of Translational Medicine.

Treatment with Dexamethasone and Monophosphoryl Lipid A Removes Disease-Associated Transcriptional Signatures in Monocyte-Derived Dendritic Cells from Rheumatoid Arthritis Patients and Confers Tolerogenic Features

Ahmed M. Mehdi, M. Molina, J. Aguillón, 2016, Front. Immunol..

Aguilón JC. Treatment with Dexamethasone and Monophosphoryl Lipid A Removes Disease-Associated Transcriptional Signatures in Monocyte-Derived Dendritic Cells from Rheumatoid Arthritis Patients and Confers Tolerogenic

Ahmed M. Mehdi, M. Molina, J. Aguillón, 2016 .